Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Diabetes Right
  3. Trulicity (dulaglutide) injection Right
  4. How do you treat a Trulicity® (dulaglutide) overdose?
Search Trulicity (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

How do you treat a Trulicity® (dulaglutide) overdose?

In the event of overdose, appropriate supportive care should be initiated according to the patient’s clinical signs and symptoms.

US_cFAQ_GLP024_OVERDOSE
US_cFAQ_GLP024_OVERDOSE
en-US

Detailed Information

Overdoses of dulaglutide have been reported in clinical studies.1

Effects of overdose with dulaglutide in clinical studies have included GI disorders and non-severe hypoglycemia.1

In the event of an overdose, appropriate supportive treatment such as frequent plasma glucose monitoring, should be initiated according to the patient’s clinical signs and symptoms.1

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

Reference

1Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Glossary

GI = gastrointestinal

Date of Last Review: July 07, 2020

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly